|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2011-4-4
|
|
pubmed:abstractText |
To analyze HER2 status in primary breast cancer (PBC) compared with correspondent metachronous metastases and to investigate whether BC phenotype may be predictive of change in HER2 expression.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/HER2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/trastuzumab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:BuglioniSimonettaS,
pubmed-author:CognettiFrancescoF,
pubmed-author:Di BenedettoAnnaA,
pubmed-author:Di FilippoFrancoF,
pubmed-author:ErcolaniCristianaC,
pubmed-author:FabiAlessandraA,
pubmed-author:FerrettiGianluigiG,
pubmed-author:MelucciElisaE,
pubmed-author:MetroGiulioG,
pubmed-author:MottoleseMarcellaM,
pubmed-author:NisticòCeciliaC,
pubmed-author:PapaldoPaolaP,
pubmed-author:PerracchioLetiziaL,
pubmed-author:SperdutiIsabellaI
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2055-64
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21307144-Adult,
pubmed-meshheading:21307144-Aged,
pubmed-meshheading:21307144-Aged, 80 and over,
pubmed-meshheading:21307144-Antibodies, Monoclonal,
pubmed-meshheading:21307144-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:21307144-Antineoplastic Agents,
pubmed-meshheading:21307144-Breast Neoplasms,
pubmed-meshheading:21307144-Chromosomes, Human, Pair 17,
pubmed-meshheading:21307144-DNA Copy Number Variations,
pubmed-meshheading:21307144-Disease-Free Survival,
pubmed-meshheading:21307144-Female,
pubmed-meshheading:21307144-Gene Amplification,
pubmed-meshheading:21307144-Humans,
pubmed-meshheading:21307144-In Situ Hybridization,
pubmed-meshheading:21307144-Middle Aged,
pubmed-meshheading:21307144-Neoadjuvant Therapy,
pubmed-meshheading:21307144-Neoplasm Metastasis,
pubmed-meshheading:21307144-Receptor, erbB-2,
pubmed-meshheading:21307144-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
HER2 protein and gene variation between primary and metastatic breast cancer: significance and impact on patient care.
|
|
pubmed:affiliation |
Medical Oncology, Regina Elena Cancer Institute, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
